About Glofitamab
            
            Class: | Monoclonal antibody (bispecific T-cell engager)  
Use: | Treatment of adult patients with relapsed or refractory B-cell non-Hodgkin lymphoma (NHL)  
Adult dose: | Initial dose of 2.5 mg administered as an intravenous infusion; subsequent doses may vary based on clinical response and tolerability  
Pediatric dose: | Safety and efficacy have not been established in pediatric patients  
Side effects: | Cytokine release syndrome, fatigue, nausea, headache, fever, chills, hypotension, and in
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (bispecific T-cell engager)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of adult patients with relapsed or refractory B-cell non-Hodgkin lymphoma (NHL)
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: F. Hoffmann-La Roche Ltd [Basel;Switzerland], Switzerland
                    
                    
                    Package Size
                    1 vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 4163.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 2.5 mg administered as an intravenous infusion; subsequent doses may vary based on clinical response and tolerability
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy have not been established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Cytokine release syndrome, fatigue, nausea, headache, fever, chills, hypotension, and infusion-related reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to glofitamab or any of its components; active infections; severe cytokine release syndrome from previous therapies
         
        
        
            
                Important Warnings
            
            Risk of cytokine release syndrome, which can be severe or life-threatening; monitor patients closely during and after infusion; potential for neurological toxicities; caution in patients with a history of autoimmune disease or infections
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.